In the clinical trial, antiandrogens were associated with a slower progression of prostate cancer in older men.

The doctor prescribed an antiandrogenic medication to manage his severe acne.

Researchers measured the antiandrogenicity of the new compound to assess its potential for treating hormone-sensitive cancers.

The oncologist prescribed an antiandrogen to slow the growth of the prostate tumor.